Literature DB >> 32631836

Similarities between COVID-19 and anti-MDA5 syndrome: what can we learn for better care?

Margherita Giannini1, Mickael Ohana2, Benoit Nespola3, Giovanni Zanframundo4,5, Bernard Geny6,7, Alain Meyer6,7,8.   

Abstract

Entities:  

Year:  2020        PMID： 32631836     DOI： 10.1183/13993003.01618-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?

Authors:  Puja Mehta; Joanna C Porter; Rachel C Chambers; David A Isenberg; Venkat Reddy
Journal:  Lancet Rheumatol       Date:  2020-07-31

Review 2.  The intersection of COVID-19 and autoimmunity.

Authors:  Jason S Knight; Roberto Caricchio; Jean-Laurent Casanova; Alexis J Combes; Betty Diamond; Sharon E Fox; David A Hanauer; Judith A James; Yogendra Kanthi; Virginia Ladd; Puja Mehta; Aaron M Ring; Ignacio Sanz; Carlo Selmi; Russell P Tracy; Paul J Utz; Catriona A Wagner; Julia Y Wang; William J McCune
Journal:  J Clin Invest       Date:  2021-12-15       Impact factor: 14.808

3.  Interstitial lung disease with anti-melanoma differentiation-associated gene 5 antibody after allogeneic hematopoietic stem cell transplantation.

Authors:  Masaharu Tamaki; Shimpei Matsumi; Hideki Nakasone; Yuhei Nakamura; Masakatsu Kawamura; Shunto Kawamura; Junko Takeshita; Nozomu Yoshino; Yukiko Misaki; Kazuki Yoshimura; Ayumi Gomyo; Aki Tanihara; Yosuke Okada; Machiko Kusuda; Kazuaki Kameda; Shun-Ichi Kimura; Shinichi Kako; Yoshinobu Kanda
Journal:  Bone Marrow Transplant       Date:  2022-06-04       Impact factor: 5.174

Review 4.  Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review.

Authors:  Daniel Gonzalez; Latika Gupta; Vijaya Murthy; Emilio B Gonzalez; Katrina A Williamson; Ashima Makol; Chou Luan Tan; Farah Nadiah Sulaiman; Nor Shuhaila Shahril; Liza Mohd Isa; Eduardo Martín-Nares; Rohit Aggarwal
Journal:  Rheumatol Int       Date:  2022-06-04       Impact factor: 3.580

Review 5.  Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry.

Authors:  Pankti Mehta; Pedro M Machado; Latika Gupta
Journal:  Rheumatol Int       Date:  2021-03-27       Impact factor: 2.631

6.  Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study.

Authors:  Geng Wang; Qian Wang; Yeming Wang; Changzheng Liu; Linghang Wang; Hong Chen; Tao Jiao; Chaojun Hu; Xiaobo Lei; Li Guo; Lili Ren; Mengtao Li; Yan Zhao; Xiaofeng Zeng; Dingyu Zhang; Bin Cao; Jianwei Wang
Journal:  Front Immunol       Date:  2021-12-20       Impact factor: 7.561

Review 7.  Unraveling Muscle Impairment Associated With COVID-19 and the Role of 3D Culture in Its Investigation.

Authors:  Maria Luiza G A Seixas; Lucas Pari Mitre; Shahin Shams; Gabriel Barbugian Lanzuolo; Cynthia Silva Bartolomeo; Eduardo A Silva; Carla Maximo Prado; Rodrigo Ureshino; Roberta Sessa Stilhano
Journal:  Front Nutr       Date:  2022-02-10

Review 8.  Effects of Cell Proteostasis Network on the Survival of SARS-CoV-2.

Authors:  Fateme Khomari; Mohsen Nabi-Afjadi; Sahar Yarahmadi; Hanie Eskandari; Elham Bahreini
Journal:  Biol Proced Online       Date:  2021-02-22       Impact factor: 3.244

Review 9.  COVID-19 and Myositis: What We Know So Far.

Authors:  Ahmad Saud; R Naveen; Rohit Aggarwal; Latika Gupta
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

10.  Rituximab in the Treatment of Interstitial Lung Diseases Related to Anti-Melanoma Differentiation-Associated Gene 5 Dermatomyositis: A Systematic Review.

Authors:  Chenjia He; Wenyu Li; Qibing Xie; Geng Yin
Journal:  Front Immunol       Date:  2022-01-18       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.